These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33607843)

  • 1. Metachronous primary cancer of the tongue and malignant lymphoma of the small intestine: A case report.
    Sugimoto K; Uejima S; Uchiyama Y; Yasue R; Nambu K; Ishikawa J; Koma Y; Akita T; Toh T; Fujimoto T
    Medicine (Baltimore); 2021 Feb; 100(7):e24806. PubMed ID: 33607843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
    Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
    Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma.
    Hu X; Zeng M; Yang SE; Liang X; Ding SS; Guo L; Li S; Wen SJ
    Medicine (Baltimore); 2017 Nov; 96(45):e8494. PubMed ID: 29137041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
    Kurita D; Miura K; Nakagawa M; Ohtake S; Sakagami M; Uchino Y; Takahashi H; Kiso S; Hojo A; Kodaira H; Yagi M; Hirabayashi Y; Kobayashi Y; Iriyama N; Kobayashi S; Hatta Y; Kura Y; Sugitani M; Takei M
    Int J Hematol; 2015 Jun; 101(6):585-93. PubMed ID: 25776837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma.
    Lee GW; Go SI; Kim SH; Hong J; Kim YR; Oh S; Kim SY; Do YR; Lee H; Lee SI; Bae SH; Oh SY; Song MK; Lee WS; Lee B; Kim JS; Kim MK; Kang HJ; Ahn JS; Yhim HY; Kim HJ; Kim SJ; Kim WS; Suh C;
    Leuk Lymphoma; 2015 Apr; 56(4):1020-6. PubMed ID: 25039351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
    Yang QX; Pei XJ; Tian XY; Li Y; Li Z
    Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial.
    Johnston PB; LaPlant B; McPhail E; Habermann TM; Inwards DJ; Micallef IN; Colgan JP; Nowakowski GS; Ansell SM; Witzig TE
    Lancet Haematol; 2016 Jul; 3(7):e309-16. PubMed ID: 27374464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma.
    Zhang MC; Fang Y; Wang L; Cheng S; Fu D; He Y; Zhao Y; Wang CF; Jiang XF; Song Q; Xu PP; Zhao WL
    Clin Epigenetics; 2020 Oct; 12(1):160. PubMed ID: 33097085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary B cell lymphoma of the tongue base: a case report.
    Bechir A; Asma A; Haifa R; Nesrine A; Yosra BY; Badreddine S; Abderrahim K
    Pan Afr Med J; 2016; 25():174. PubMed ID: 28292136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Large B-Cell Lymphoma With Cardiac Invasion Presented as Acute Myocardial Infarction and Left Ventricular Hypertrophy: A Case Report.
    Liu Z; Pan X; Mo J; Deng T; Cen T; Wei B; Chen C
    J Investig Med High Impact Case Rep; 2024; 12():23247096241253334. PubMed ID: 38747509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of primary hepato-biliary malignant lymphoma effectively treated with R-CHOP chemotherapy].
    Hiramoto K; Kuroki M; Shoji H; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H; Kimura J; Matsuda M
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1345-8. PubMed ID: 20647724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.
    Seo S; Hong JY; Yoon S; Yoo C; Park JH; Lee JB; Park CS; Huh J; Lee Y; Kim KW; Ryu JS; Kim SJ; Kim WS; Yoon DH; Suh C
    Oncotarget; 2016 Nov; 7(47):76934-76943. PubMed ID: 27764777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of the addition of rituximab to CHOP in young patients with good-prognosis diffuse large-B-cell lymphoma.
    Ferrara F; Ravasio R
    Clin Drug Investig; 2008; 28(1):55-65. PubMed ID: 18081361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bendamustine plus Rituximab versus R-miniCHOP: which is better for unfit patients with diffuse larger B-cell lymphoma?
    Zhang D; Dong Y; Zhang L
    J Chemother; 2024 Jul; 36(4):351-353. PubMed ID: 37272120
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphoma.
    Arakaki H; Nakazato T; Osada Y; Ito C; Aisa Y; Mori T
    Ann Hematol; 2017 Jul; 96(7):1225-1226. PubMed ID: 28508175
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery: A case report and review of literature.
    Jia J; Li W; Zheng Y
    Medicine (Baltimore); 2017 Feb; 96(8):e6161. PubMed ID: 28225499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients.
    Pfreundschuh M; Murawski N; Zeynalova S; Ziepert M; Loeffler M; Hänel M; Dierlamm J; Keller U; Dreyling M; Truemper L; Frickhofen N; Hünerlitürkoglu AN; Schmitz N; Pöschel V; Rixecker T; Berdel C; Rübe C; Held G; Zwick C
    Br J Haematol; 2017 Nov; 179(3):410-420. PubMed ID: 28990173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under
    Gutsch J; Werthmann PG; Rosenwald A; Kienle GS
    Anticancer Res; 2018 Sep; 38(9):5363-5369. PubMed ID: 30194190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of primary malignant lymphoma of the bladder].
    Goto D; Otani T; Tomioka A; Maruyama Y
    Hinyokika Kiyo; 2013 Sep; 59(9):583-6. PubMed ID: 24113757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.